Toxic PARP trapping upon cAMP-induced DNA damage reinstates the efficacy of endocrine therapy and CDK4/6 inhibitors in treatment-refractory ER+ breast cancer

por Saatci, Ozge, Cetin, Metin, Uner, Meral, Tokat, Unal Metin, Chatzistamou, Ioulia, Ersan, Pelin Gulizar, Montaudon, Elodie, Akyol, Aytekin, Aksoy, Sercan, Uner, Aysegul, Marangoni, Elisabetta, Sajish, Mathew, Sahin, Ozgur
Publicado 2023

The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer

por Raza, Umar, Saatci, Özge, Uhlmann, Stefan, Ansari, Suhail A, Eyüpoğlu, Erol, Yurdusev, Emre, Mutlu, Merve, Ersan, Pelin Gülizar, Altundağ, Mustafa Kadri, Zhang, Jitao David, Doğan, Hayriye Tatlı, Güler, Gülnur, Şahin, Özgür
Publicado 2016